Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
10.11
+0.22 (2.23%)
Nov 21, 2024, 12:39 PM EST - Market open
Enfusion Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Enfusion stock have an average target of 9.00, with a low estimate of 8.00 and a high estimate of 10. The average target predicts a decrease of -10.98% from the current stock price of 10.11.
Analyst Consensus: Sell
* Price targets were last updated on Mar 13, 2024.
Analyst Ratings
The average analyst rating for Enfusion stock from 4 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 6 | 6 | 6 | 6 | 6 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -10.98% | Mar 13, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Sell Downgrades $9 → $8 | Hold → Strong Sell | Downgrades | $9 → $8 | -20.87% | Feb 28, 2024 |
| JP Morgan | JP Morgan | Hold → Sell Downgrades $11 → $9 | Hold → Sell | Downgrades | $11 → $9 | -10.98% | Jan 30, 2024 |
| Piper Sandler | Piper Sandler | Hold Maintains $9 → $10 | Hold | Maintains | $9 → $10 | -1.09% | Dec 20, 2023 |
| UBS | UBS | Hold Initiates $9 | Hold | Initiates | $9 | -10.98% | Nov 7, 2023 |
Financial Forecast
Revenue This Year
207.49M
from 174.54M
Increased by 18.88%
Revenue Next Year
244.27M
from 207.49M
Increased by 17.73%
EPS This Year
0.22
from 0.06
Increased by 234.29%
EPS Next Year
0.30
from 0.22
Increased by 37.65%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 215.3M | 255.3M | 307.4M |
| Avg | 207.5M | 244.3M | 287.3M |
| Low | 198.3M | 229.0M | 263.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 23.4% | 23.0% | 25.9% |
| Avg | 18.9% | 17.7% | 17.6% |
| Low | 13.6% | 10.4% | 7.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.25 | 0.37 | 0.48 |
| Avg | 0.22 | 0.30 | 0.38 |
| Low | 0.18 | 0.21 | 0.28 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 288.7% | 69.6% | 61.9% |
| Avg | 234.3% | 37.6% | 28.9% |
| Low | 172.1% | -5.1% | -4.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.